CRC Tier 1 - Tools and resources for systematically discovering clinically-relevant biomarkers of cancer

David A Fruman

TOR Kinase Inhibitors for Leukemia Therapy: Mechanisms of Action and Resistance

Leukaemia

Pathology Hematology and hematologic malignancies

Wan Lam

An integrative approach to understand lung cancer development in smokers and non-smokers

Trachea, bronchus and lung

Pathology

Nola M Hylton-Watson

Quantitative Imaging for Assessing Breast Cancer Response to Treatment

Breast

Philip Lazarus

Role of Pharmacogenetics on Exemestane Metabolism and Toxicity

Breast

Gary E Fraser

Plant-Based Diets and Risk of Cancer

Prostate Breast

Richard Aplenc

Toxicity Monitoring on Phase III Trials with Administrative Data

Leukaemia

Hematology and hematologic malignancies Pediatric oncology or childhood cancer

Charles D Blanke

SWOG Network Group Operations Center of the NCTN

Breast Pancreas Oesophagus Prostate Ovary Trachea, bronchus and lung Melanoma of skin Leukaemia

Marc Servant

The role of two family of protein kinases involved in the production of many proinflammatory cytokines associated with cancer, atherosclerosis and autoimmune diseases development (CANADA RESEARCH CHAIRHOLDER)

Melanoma of skin

Theodore Brown

Sustained ovulation-associated inflammatory signaling in fallopian tube epithelium as a predisposing factor of serous carcinoma

Ovary